Latest News From BioPharmaChem


  • Happy New Year

    07 January, 2013

    Pharmachem would like to wish all our members the best for 2013. We are looking forward to working with you this Year.

    Continue Reading »

  • FDA approves new seasonal influenza vaccine made using novel technology

    17 January, 2013

    The U.S. Food and Drug Administration has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

    Continue Reading »

  • Career Zoo: The Convention Centre Dublin 09/02/2013

    24 January, 2013

    Register your place.

    Continue Reading »

  • February

  • Diclofenac used and recommended globally, despite cardiovascular risks

    13 February, 2013

    A study in this week's PLOS Medicine finds that the painkiller diclofenac (a non-steroidal anti-inflammatory drug (NSAID) in the same class as aspirin) is the most commonly used NSAID in the 15 countries studied and is included in the essential medicines lists of 74 low-, middle- and high-income countries, despite its known tendency to cause heart attacks and strokes in vulnerable patients.

    Continue Reading »

  • April

  • Novartis delivered solid performance in the first quarter

    24 April, 2013

    Novartis Novartis net sales increased 2% (+4% cc) to USD 14.0 billion in the first quarter, with all divisions contributing to growth. Currency had a negative impact of 2 percentage points. Excluding the impact of patent expiries, underlying sales grew 7%. This was fueled by growth products such as Gilenya, Afinitor, Tasigna, Galvus, Lucentis, Xolair, Arcapta Neohaler/Onbrez Breezhaler and Jakavi, which together contributed USD 4.2 billion or 30% of Group net sales, up 14% over the prior-year period.

    Continue Reading »

  • May

  • Breakup of physician, drug company relationship could improve health care, cut cost

    21 May, 2013

    A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, more costly and often unnecessary prescription drugs. This system, which has been in place for decades, at one time benefitted doctors by keeping them up to date on new medications, and always provided generous amounts of "free" samples to get patients started on the newest drugs, as well as other supplies and gifts.

    Continue Reading »

  • June

  • Big Multiple Sclerosis Breakthrough

    06 June, 2013

    A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine research. In MS, the immune system attacks and destroys myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve. When the insulation is destroyed, electrical signals can't be effectively conducted, resulting in symptoms that range from mild limb numbness to paralysis or blindness.

    Continue Reading »

  • Get Your Foot In The Door Workshop 26/06/2013 Silversprings Hotel

    12 June, 2013

    The aim of this event is to give people wishing to enter the Pharmaceutical/Chemical/Medical Device sector the opportunity to meet professionals from the industry and to hear the types of skills required in today's climate. There will be a number of career coaches, industry professionals and recruitment agencies available to speak to on the night and 1 hour training overviews on " Conversion to the Pharmaceutical and Medical Device Sector and Communication/Interview Skills - Selling yourself at your best" so even if you are unsure as to what path you want to take but would like a bit of advice please feel free to come along. We will have people there from Novartis, Merck Millipore, Gilead Sciences, Sanmina, Pfizer, DePuy, Cara Partners and FMC so it is a great opportunity to network and "get your foot in the door". Agenda. Please book on line:

    Continue Reading »

  • July

  • €40m Irish Govt-industry investment in UL

    03 July, 2013

    €40m Irish Govt-industry investment in UL pharma centre to put Ireland on global innovation map

    Continue Reading »

  • Pfizer to create some 250 jobs with US$130m investment in Irish plants

    16 July, 2013

    Pharmaceutical company Pfizer is to create up to 250 construction jobs on the back of investments worth US$130m for two of its Irish plants.

    Continue Reading »

  • Career Zoo

    29 July, 2013

    Ireland’s biggest career event for professionals and graduates, Career Zoo, returns to The Convention Centre Dublin this September 14th.

    Continue Reading »

  • August

  • Jobs Expo Dublin & Cork (Supported by Chamber of Commerce)

    23 August, 2013

    Continue Reading »

  • September

  • Career Zoo Sept 14th 2013

    13 September, 2013

    Get ready for Ireland's biggest and most exciting career event for professionals and graduates looking to advance their careers. The next Career Zoo event is confirmed for Saturday 14th September 2013 at The Convention Centre Dublin. Admission is FREE and registration is now open.

    Continue Reading »

  • November

  • 7 Habits of Highly Effective People - 1/2 day overview

    06 November, 2013

    We are delighted to host a half day overview of the 7 Habits of HIghly Effective people facilitated by FranklinCovey.

    Continue Reading »

  • December

  • Seasons Greetings to all our Members

    20 December, 2013

    The PharmachemSkillnet would like to wish all our member companies a Merry Christmas and a Happy New Year. We are here to help you in achieving your training goals no matter how large are small they might be.

    Continue Reading »